[
    [
        {
            "time": "2021-11",
            "original_text": "2021年医药行业11月策略报告：战略布局特色原料药及高景气度子行业",
            "features": {
                "keywords": [
                    "医药行业",
                    "战略布局",
                    "特色原料药",
                    "高景气度",
                    "子行业"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "原料药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年医药行业11月策略报告：战略布局特色原料药及高景气度子行业",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-xx",
            "original_text": "医药生物行业跨市场周报：辉瑞新冠药中期数据优异 新冠有望进一步流感化",
            "features": {
                "keywords": [
                    "医药生物",
                    "辉瑞",
                    "新冠药",
                    "中期数据",
                    "流感化"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报：辉瑞新冠药中期数据优异 新冠有望进一步流感化",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]